How Do Prices of Drugs for Weight Loss in the U.S. Compare to Peer Nations’ Prices?

A class of drugs initially approved for diabetes treatment has captured the public’s and policymakers’ attention as interest in their off-label use for weight loss rises. The weight-loss benefits of these drugs have led to their prescribed use for obesity or overweight treatment. A new analysis compares list prices for semaglutide—including Ozempic, which has been…More

Read the full post on Reports on Health Insurance and Health Care Costs from the Kaiser Family Foundation